GB901093A — Steroids
Assigned to MSD International Holdings GmbH · Expires 1962-07-11 · 64y expired
What this patent protects
901,093. Steroids. SCHERICO Ltd. July 22, 1958 [July 22, 1957; May 8, 1958], No. 7840/62. Divided out of 901,092. Class 2(3). The invention comprises steroids of the pregnane 5α, 5# or #<SP>5(6)</SP> series having a 3- hydroxy or acyloxy group, a 20-keto group, an 11-…
USPTO Abstract
901,093. Steroids. SCHERICO Ltd. July 22, 1958 [July 22, 1957; May 8, 1958], No. 7840/62. Divided out of 901,092. Class 2(3). The invention comprises steroids of the pregnane 5α, 5# or #<SP>5(6)</SP> series having a 3- hydroxy or acyloxy group, a 20-keto group, an 11-hydroxy or keto group and at C 16 and C 17 an alkylenediazo grouping, said compound having a D ring with substituents as shown in the formula wherein R represents hydrogen or an alkyl group containing 1 to 5 carbon atoms, and the preparation thereof by reacting the corresponding 16(17)-ene compounds with diazomethane (in the case where R represents hydrogen) or with a diazoalkane containing 2 to 6 carbon atoms (in the case where R represents an alkyl group containing 1 to 5 carbon atoms).
Drugs covered by this patent
- Agamree (VAMOROLONE) · Catalyst Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.